Japan and France's lower prevalence rates were linked to fewer risk factors such as obesity.
Japan and France's lower prevalence rates were linked to fewer risk factors such as obesity. Japan is projected to have approximately 15.3 million diagnosed prevalent cases of dyslipidemia in 2035, according to GlobalData. The number of diagnosed cases across the seven major markets (7MM) is forecast to increase at an annual growth rate (AGR) of 0.58%, from 131.6 million in 2025 to 139.2 million in 2035.
Dyslipidemia is a medical condition characterised by abnormal levels of lipids in the bloodstream, including cholesterol, low-density lipoprotein cholesterol, triglycerides, and high-density…
Read the full report on Healthcare Asia Magazine
Story file
- Section
- Health
- First reported by
- Healthcare Asia Magazine
- Reporter
- staff reporter
- Published
- Monday, 12 October 2026, 9:15 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Healthcare Asia Magazine with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
